nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—Tripelennamine—Rosiglitazone—type 2 diabetes mellitus	0.137	1	CrCrCtD
Tamoxifen—ABCC2—type 2 diabetes mellitus	0.0934	0.356	CbGaD
Tamoxifen—CYP2E1—type 2 diabetes mellitus	0.0656	0.25	CbGaD
Tamoxifen—CYP1A2—type 2 diabetes mellitus	0.0624	0.237	CbGaD
Tamoxifen—CYP3A4—type 2 diabetes mellitus	0.0413	0.157	CbGaD
Tamoxifen—ABCB11—Glyburide—type 2 diabetes mellitus	0.0174	0.0497	CbGbCtD
Tamoxifen—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0162	0.046	CbGbCtD
Tamoxifen—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0119	0.034	CbGbCtD
Tamoxifen—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00954	0.0272	CbGbCtD
Tamoxifen—ABCC2—Glyburide—type 2 diabetes mellitus	0.00917	0.0261	CbGbCtD
Tamoxifen—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00907	0.0258	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00907	0.0258	CbGbCtD
Tamoxifen—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00907	0.0258	CbGbCtD
Tamoxifen—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00863	0.0246	CbGbCtD
Tamoxifen—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00851	0.0243	CbGbCtD
Tamoxifen—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00833	0.0237	CbGbCtD
Tamoxifen—ABCG2—Glyburide—type 2 diabetes mellitus	0.00829	0.0236	CbGbCtD
Tamoxifen—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00808	0.023	CbGbCtD
Tamoxifen—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00796	0.0227	CbGbCtD
Tamoxifen—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00769	0.0219	CbGbCtD
Tamoxifen—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00761	0.0217	CbGbCtD
Tamoxifen—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00724	0.0206	CbGbCtD
Tamoxifen—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00724	0.0206	CbGbCtD
Tamoxifen—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00708	0.0202	CbGbCtD
Tamoxifen—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0068	0.0194	CbGbCtD
Tamoxifen—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00668	0.019	CbGbCtD
Tamoxifen—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00645	0.0184	CbGbCtD
Tamoxifen—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00627	0.0179	CbGbCtD
Tamoxifen—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00617	0.0176	CbGbCtD
Tamoxifen—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00602	0.0171	CbGbCtD
Tamoxifen—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00602	0.0171	CbGbCtD
Tamoxifen—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00584	0.0166	CbGbCtD
Tamoxifen—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00556	0.0158	CbGbCtD
Tamoxifen—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0055	0.0157	CbGbCtD
Tamoxifen—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00543	0.0155	CbGbCtD
Tamoxifen—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00537	0.0153	CbGbCtD
Tamoxifen—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00508	0.0145	CbGbCtD
Tamoxifen—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00491	0.014	CbGbCtD
Tamoxifen—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00485	0.0138	CbGbCtD
Tamoxifen—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00484	0.0138	CbGbCtD
Tamoxifen—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00459	0.0131	CbGbCtD
Tamoxifen—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00456	0.013	CbGbCtD
Tamoxifen—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00443	0.0126	CbGbCtD
Tamoxifen—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00437	0.0125	CbGbCtD
Tamoxifen—CYP3A5—Losartan—type 2 diabetes mellitus	0.0042	0.012	CbGbCtD
Tamoxifen—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00417	0.0119	CbGbCtD
Tamoxifen—CYP2C8—Losartan—type 2 diabetes mellitus	0.00404	0.0115	CbGbCtD
Tamoxifen—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00401	0.0114	CbGbCtD
Tamoxifen—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.004	0.0114	CbGbCtD
Tamoxifen—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00387	0.011	CbGbCtD
Tamoxifen—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00371	0.0106	CbGbCtD
Tamoxifen—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0035	0.00997	CbGbCtD
Tamoxifen—CYP2C19—Losartan—type 2 diabetes mellitus	0.00339	0.00966	CbGbCtD
Tamoxifen—CYP1A2—Losartan—type 2 diabetes mellitus	0.00313	0.00891	CbGbCtD
Tamoxifen—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00308	0.00878	CbGbCtD
Tamoxifen—ABCB1—Glyburide—type 2 diabetes mellitus	0.00299	0.00852	CbGbCtD
Tamoxifen—CYP2C9—Losartan—type 2 diabetes mellitus	0.00282	0.00803	CbGbCtD
Tamoxifen—ABCB1—Losartan—type 2 diabetes mellitus	0.00274	0.00779	CbGbCtD
Tamoxifen—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00265	0.00756	CbGbCtD
Tamoxifen—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00254	0.00724	CbGbCtD
Tamoxifen—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00254	0.00724	CbGbCtD
Tamoxifen—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0024	0.00685	CbGbCtD
Tamoxifen—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00179	0.0051	CbGbCtD
Tamoxifen—CYP3A4—Losartan—type 2 diabetes mellitus	0.00164	0.00467	CbGbCtD
Tamoxifen—EBPL—adipose tissue—type 2 diabetes mellitus	0.000834	0.0281	CbGeAlD
Tamoxifen—DHCR7—islet of Langerhans—type 2 diabetes mellitus	0.000738	0.0249	CbGeAlD
Tamoxifen—SULT1A1—kidney—type 2 diabetes mellitus	0.000735	0.0247	CbGeAlD
Tamoxifen—ESRRA—islet of Langerhans—type 2 diabetes mellitus	0.000727	0.0245	CbGeAlD
Tamoxifen—EBP—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000709	1	CbGdCrCtD
Tamoxifen—SULT1A1—adipose tissue—type 2 diabetes mellitus	0.000662	0.0223	CbGeAlD
Tamoxifen—UGT1A4—kidney—type 2 diabetes mellitus	0.000641	0.0216	CbGeAlD
Tamoxifen—DHCR7—retina—type 2 diabetes mellitus	0.000631	0.0213	CbGeAlD
Tamoxifen—DHCR7—nephron tubule—type 2 diabetes mellitus	0.000595	0.02	CbGeAlD
Tamoxifen—FMO1—nephron tubule—type 2 diabetes mellitus	0.000595	0.02	CbGeAlD
Tamoxifen—ESRRA—nephron tubule—type 2 diabetes mellitus	0.000585	0.0197	CbGeAlD
Tamoxifen—EBPL—liver—type 2 diabetes mellitus	0.000585	0.0197	CbGeAlD
Tamoxifen—EBP—liver—type 2 diabetes mellitus	0.00056	0.0189	CbGeAlD
Tamoxifen—ESRRA—cardiovascular system—type 2 diabetes mellitus	0.000526	0.0177	CbGeAlD
Tamoxifen—FMO1—kidney—type 2 diabetes mellitus	0.000523	0.0176	CbGeAlD
Tamoxifen—DHCR7—pancreas—type 2 diabetes mellitus	0.000519	0.0175	CbGeAlD
Tamoxifen—ESRRA—kidney—type 2 diabetes mellitus	0.000514	0.0173	CbGeAlD
Tamoxifen—ESRRA—pancreas—type 2 diabetes mellitus	0.000511	0.0172	CbGeAlD
Tamoxifen—DHCR7—cortex of kidney—type 2 diabetes mellitus	0.000509	0.0171	CbGeAlD
Tamoxifen—FMO1—cortex of kidney—type 2 diabetes mellitus	0.000509	0.0171	CbGeAlD
Tamoxifen—ESRRA—cortex of kidney—type 2 diabetes mellitus	0.000501	0.0169	CbGeAlD
Tamoxifen—DHCR7—adipose tissue—type 2 diabetes mellitus	0.000471	0.0159	CbGeAlD
Tamoxifen—FMO1—adipose tissue—type 2 diabetes mellitus	0.000471	0.0159	CbGeAlD
Tamoxifen—SULT1A1—liver—type 2 diabetes mellitus	0.000464	0.0156	CbGeAlD
Tamoxifen—ESRRA—adipose tissue—type 2 diabetes mellitus	0.000464	0.0156	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000432	0.0146	CbGeAlD
Tamoxifen—FMO3—adipose tissue—type 2 diabetes mellitus	0.000407	0.0137	CbGeAlD
Tamoxifen—UGT1A4—liver—type 2 diabetes mellitus	0.000405	0.0136	CbGeAlD
Tamoxifen—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00037	0.0125	CbGeAlD
Tamoxifen—CES1—cardiovascular system—type 2 diabetes mellitus	0.000364	0.0123	CbGeAlD
Tamoxifen—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000338	0.0114	CbGeAlD
Tamoxifen—DHCR7—liver—type 2 diabetes mellitus	0.00033	0.0111	CbGeAlD
Tamoxifen—FMO1—liver—type 2 diabetes mellitus	0.00033	0.0111	CbGeAlD
Tamoxifen—ESRRA—liver—type 2 diabetes mellitus	0.000325	0.011	CbGeAlD
Tamoxifen—CES1—adipose tissue—type 2 diabetes mellitus	0.000321	0.0108	CbGeAlD
Tamoxifen—ESR2—cardiovascular system—type 2 diabetes mellitus	0.000316	0.0106	CbGeAlD
Tamoxifen—ESR2—kidney—type 2 diabetes mellitus	0.000309	0.0104	CbGeAlD
Tamoxifen—ABCB11—liver—type 2 diabetes mellitus	0.000289	0.00972	CbGeAlD
Tamoxifen—FMO3—liver—type 2 diabetes mellitus	0.000285	0.00962	CbGeAlD
Tamoxifen—CYP3A7—liver—type 2 diabetes mellitus	0.000282	0.00951	CbGeAlD
Tamoxifen—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.00028	0.00942	CbGeAlD
Tamoxifen—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000272	0.00917	CbGeAlD
Tamoxifen—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000264	0.0089	CbGeAlD
Tamoxifen—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000259	0.00872	CbGeAlD
Tamoxifen—Clomifene—CYP11A1—type 2 diabetes mellitus	0.000248	0.106	CrCbGaD
Tamoxifen—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.00024	0.00809	CbGeAlD
Tamoxifen—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000238	0.008	CbGeAlD
Tamoxifen—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000233	0.00785	CbGeAlD
Tamoxifen—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000232	0.00783	CbGeAlD
Tamoxifen—ABCC2—kidney—type 2 diabetes mellitus	0.000232	0.00782	CbGeAlD
Tamoxifen—CYP1B1—kidney—type 2 diabetes mellitus	0.000227	0.00766	CbGeAlD
Tamoxifen—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000226	0.00762	CbGeAlD
Tamoxifen—CES1—liver—type 2 diabetes mellitus	0.000225	0.00759	CbGeAlD
Tamoxifen—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000222	0.00748	CbGeAlD
Tamoxifen—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000222	0.00746	CbGeAlD
Tamoxifen—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000219	0.00739	CbGeAlD
Tamoxifen—ESR1—cardiovascular system—type 2 diabetes mellitus	0.000216	0.00728	CbGeAlD
Tamoxifen—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000216	0.00726	CbGeAlD
Tamoxifen—ESR1—kidney—type 2 diabetes mellitus	0.000211	0.00712	CbGeAlD
Tamoxifen—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000205	0.0069	CbGeAlD
Tamoxifen—CYP2A6—liver—type 2 diabetes mellitus	0.000196	0.00661	CbGeAlD
Tamoxifen—ESR2—liver—type 2 diabetes mellitus	0.000195	0.00657	CbGeAlD
Tamoxifen—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000193	0.00649	CbGeAlD
Tamoxifen—ESR1—adipose tissue—type 2 diabetes mellitus	0.000191	0.00642	CbGeAlD
Tamoxifen—Loperamide—CALM1—type 2 diabetes mellitus	0.000186	0.0792	CrCbGaD
Tamoxifen—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000179	0.00603	CbGeAlD
Tamoxifen—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000178	0.00599	CbGeAlD
Tamoxifen—CYP2C8—kidney—type 2 diabetes mellitus	0.000174	0.00587	CbGeAlD
Tamoxifen—Bedaquiline—CYP3A4—type 2 diabetes mellitus	0.000171	0.0726	CrCbGaD
Tamoxifen—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000167	0.00562	CbGeAlD
Tamoxifen—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000164	0.0697	CrCbGaD
Tamoxifen—CYP1A1—kidney—type 2 diabetes mellitus	0.000161	0.00542	CbGeAlD
Tamoxifen—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.00016	0.00538	CbGeAlD
Tamoxifen—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000158	0.00533	CbGeAlD
Tamoxifen—CYP3A5—kidney—type 2 diabetes mellitus	0.000157	0.0053	CbGeAlD
Tamoxifen—CYP2B6—kidney—type 2 diabetes mellitus	0.000156	0.00526	CbGeAlD
Tamoxifen—CYP3A5—pancreas—type 2 diabetes mellitus	0.000156	0.00526	CbGeAlD
Tamoxifen—CYP19A1—liver—type 2 diabetes mellitus	0.000154	0.00518	CbGeAlD
Tamoxifen—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000153	0.00516	CbGeAlD
Tamoxifen—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000153	0.00514	CbGeAlD
Tamoxifen—SIGMAR1—liver—type 2 diabetes mellitus	0.000151	0.00509	CbGeAlD
Tamoxifen—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.00015	0.00505	CbGeAlD
Tamoxifen—ABCC2—liver—type 2 diabetes mellitus	0.000147	0.00494	CbGeAlD
Tamoxifen—CYP2E1—kidney—type 2 diabetes mellitus	0.000147	0.00494	CbGeAlD
Tamoxifen—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000145	0.00488	CbGeAlD
Tamoxifen—CYP1B1—liver—type 2 diabetes mellitus	0.000144	0.00484	CbGeAlD
Tamoxifen—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000143	0.00481	CbGeAlD
Tamoxifen—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000142	0.00477	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP2E1—type 2 diabetes mellitus	0.00014	0.0594	CrCbGaD
Tamoxifen—ESR1—liver—type 2 diabetes mellitus	0.000134	0.0045	CbGeAlD
Tamoxifen—CYP2C19—liver—type 2 diabetes mellitus	0.000126	0.00425	CbGeAlD
Tamoxifen—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000118	0.00398	CbGeAlD
Tamoxifen—CYP3A4—kidney—type 2 diabetes mellitus	0.000118	0.00397	CbGeAlD
Tamoxifen—CYP2D6—kidney—type 2 diabetes mellitus	0.000116	0.00391	CbGeAlD
Tamoxifen—CYP2C8—liver—type 2 diabetes mellitus	0.00011	0.00371	CbGeAlD
Tamoxifen—ABCG2—liver—type 2 diabetes mellitus	0.000107	0.00361	CbGeAlD
Tamoxifen—Toremifene—CYP1A2—type 2 diabetes mellitus	0.000105	0.0448	CrCbGaD
Tamoxifen—CYP1A2—liver—type 2 diabetes mellitus	0.000103	0.00347	CbGeAlD
Tamoxifen—CYP1A1—liver—type 2 diabetes mellitus	0.000102	0.00342	CbGeAlD
Tamoxifen—ABCB1—retina—type 2 diabetes mellitus	0.000101	0.0034	CbGeAlD
Tamoxifen—CYP3A5—liver—type 2 diabetes mellitus	9.94e-05	0.00335	CbGeAlD
Tamoxifen—CYP2B6—liver—type 2 diabetes mellitus	9.88e-05	0.00333	CbGeAlD
Tamoxifen—CYP2C9—liver—type 2 diabetes mellitus	9.78e-05	0.00329	CbGeAlD
Tamoxifen—Clomifene—CYP2E1—type 2 diabetes mellitus	9.57e-05	0.0407	CrCbGaD
Tamoxifen—ABCB1—nephron tubule—type 2 diabetes mellitus	9.5e-05	0.0032	CbGeAlD
Tamoxifen—CYP2E1—liver—type 2 diabetes mellitus	9.27e-05	0.00312	CbGeAlD
Tamoxifen—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	9.1e-05	0.0387	CrCbGaD
Tamoxifen—Clomifene—CYP1A2—type 2 diabetes mellitus	9.1e-05	0.0387	CrCbGaD
Tamoxifen—Diethylstilbestrol—CYP3A4—type 2 diabetes mellitus	8.79e-05	0.0374	CrCbGaD
Tamoxifen—Ospemifene—CYP3A4—type 2 diabetes mellitus	8.55e-05	0.0364	CrCbGaD
Tamoxifen—ABCB1—cardiovascular system—type 2 diabetes mellitus	8.54e-05	0.00288	CbGeAlD
Tamoxifen—ABCB1—kidney—type 2 diabetes mellitus	8.35e-05	0.00281	CbGeAlD
Tamoxifen—ABCB1—pancreas—type 2 diabetes mellitus	8.3e-05	0.00279	CbGeAlD
Tamoxifen—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.13e-05	0.00274	CbGeAlD
Tamoxifen—Benzphetamine—ADRA2A—type 2 diabetes mellitus	7.76e-05	0.033	CrCbGaD
Tamoxifen—ABCB1—adipose tissue—type 2 diabetes mellitus	7.53e-05	0.00254	CbGeAlD
Tamoxifen—CYP3A4—liver—type 2 diabetes mellitus	7.46e-05	0.00251	CbGeAlD
Tamoxifen—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	7.42e-05	0.0315	CrCbGaD
Tamoxifen—CYP2D6—liver—type 2 diabetes mellitus	7.34e-05	0.00247	CbGeAlD
Tamoxifen—Toremifene—CYP3A4—type 2 diabetes mellitus	6.97e-05	0.0297	CrCbGaD
Tamoxifen—Clomifene—CYP3A4—type 2 diabetes mellitus	6.03e-05	0.0256	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	6.03e-05	0.0256	CrCbGaD
Tamoxifen—Promazine—ADRA2A—type 2 diabetes mellitus	5.36e-05	0.0228	CrCbGaD
Tamoxifen—Paraesthesia—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000409	CcSEcCtD
Tamoxifen—Hepatitis—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000408	CcSEcCtD
Tamoxifen—Anaemia—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000407	CcSEcCtD
Tamoxifen—Dizziness—Glimepiride—type 2 diabetes mellitus	5.28e-05	0.000406	CcSEcCtD
Tamoxifen—ABCB1—liver—type 2 diabetes mellitus	5.28e-05	0.00178	CbGeAlD
Tamoxifen—Dysgeusia—Losartan—type 2 diabetes mellitus	5.28e-05	0.000406	CcSEcCtD
Tamoxifen—Dyspnoea—Gliclazide—type 2 diabetes mellitus	5.28e-05	0.000406	CcSEcCtD
Tamoxifen—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.27e-05	0.000405	CcSEcCtD
Tamoxifen—Hypertension—Metformin—type 2 diabetes mellitus	5.24e-05	0.000403	CcSEcCtD
Tamoxifen—Urticaria—Glyburide—type 2 diabetes mellitus	5.23e-05	0.000403	CcSEcCtD
Tamoxifen—Angioedema—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000402	CcSEcCtD
Tamoxifen—Oedema peripheral—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000402	CcSEcCtD
Tamoxifen—Back pain—Losartan—type 2 diabetes mellitus	5.21e-05	0.000401	CcSEcCtD
Tamoxifen—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.21e-05	0.000401	CcSEcCtD
Tamoxifen—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.21e-05	0.000401	CcSEcCtD
Tamoxifen—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	5.19e-05	0.000399	CcSEcCtD
Tamoxifen—Anorexia—Valsartan—type 2 diabetes mellitus	5.18e-05	0.000398	CcSEcCtD
Tamoxifen—Muscle spasms—Losartan—type 2 diabetes mellitus	5.18e-05	0.000398	CcSEcCtD
Tamoxifen—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.17e-05	0.000398	CcSEcCtD
Tamoxifen—Myalgia—Metformin—type 2 diabetes mellitus	5.16e-05	0.000397	CcSEcCtD
Tamoxifen—Chest pain—Metformin—type 2 diabetes mellitus	5.16e-05	0.000397	CcSEcCtD
Tamoxifen—Headache—Pioglitazone—type 2 diabetes mellitus	5.14e-05	0.000395	CcSEcCtD
Tamoxifen—Leukopenia—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000394	CcSEcCtD
Tamoxifen—Visual impairment—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000393	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.000393	CcSEcCtD
Tamoxifen—Discomfort—Metformin—type 2 diabetes mellitus	5.1e-05	0.000392	CcSEcCtD
Tamoxifen—Fatigue—Gliclazide—type 2 diabetes mellitus	5.1e-05	0.000392	CcSEcCtD
Tamoxifen—Nausea—Glipizide—type 2 diabetes mellitus	5.09e-05	0.000391	CcSEcCtD
Tamoxifen—Vomiting—Glimepiride—type 2 diabetes mellitus	5.08e-05	0.000391	CcSEcCtD
Tamoxifen—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.06e-05	0.000389	CcSEcCtD
Tamoxifen—Constipation—Gliclazide—type 2 diabetes mellitus	5.06e-05	0.000389	CcSEcCtD
Tamoxifen—Pain—Gliclazide—type 2 diabetes mellitus	5.06e-05	0.000389	CcSEcCtD
Tamoxifen—Rash—Glimepiride—type 2 diabetes mellitus	5.04e-05	0.000387	CcSEcCtD
Tamoxifen—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.03e-05	0.000387	CcSEcCtD
Tamoxifen—Rash—Sitagliptin—type 2 diabetes mellitus	5.02e-05	0.000386	CcSEcCtD
Tamoxifen—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.02e-05	0.000386	CcSEcCtD
Tamoxifen—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000386	CcSEcCtD
Tamoxifen—Headache—Glimepiride—type 2 diabetes mellitus	5.01e-05	0.000385	CcSEcCtD
Tamoxifen—Cough—Irbesartan—type 2 diabetes mellitus	5e-05	0.000384	CcSEcCtD
Tamoxifen—Headache—Sitagliptin—type 2 diabetes mellitus	4.99e-05	0.000384	CcSEcCtD
Tamoxifen—Anaemia—Losartan—type 2 diabetes mellitus	4.98e-05	0.000383	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.95e-05	0.000381	CcSEcCtD
Tamoxifen—Oedema—Metformin—type 2 diabetes mellitus	4.95e-05	0.000381	CcSEcCtD
Tamoxifen—Hypertension—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.00038	CcSEcCtD
Tamoxifen—Promazine—HTR2C—type 2 diabetes mellitus	4.94e-05	0.021	CrCbGaD
Tamoxifen—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.93e-05	0.000379	CcSEcCtD
Tamoxifen—Flushing—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000379	CcSEcCtD
Tamoxifen—Angioedema—Losartan—type 2 diabetes mellitus	4.92e-05	0.000379	CcSEcCtD
Tamoxifen—Infection—Metformin—type 2 diabetes mellitus	4.92e-05	0.000378	CcSEcCtD
Tamoxifen—Insomnia—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000378	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.89e-05	0.000376	CcSEcCtD
Tamoxifen—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.88e-05	0.000375	CcSEcCtD
Tamoxifen—Chest pain—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000375	CcSEcCtD
Tamoxifen—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000375	CcSEcCtD
Tamoxifen—Myalgia—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000375	CcSEcCtD
Tamoxifen—Insomnia—Orlistat—type 2 diabetes mellitus	4.86e-05	0.000374	CcSEcCtD
Tamoxifen—Anxiety—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000373	CcSEcCtD
Tamoxifen—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.85e-05	0.000373	CcSEcCtD
Tamoxifen—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.85e-05	0.000373	CcSEcCtD
Tamoxifen—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.85e-05	0.000373	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.84e-05	0.000372	CcSEcCtD
Tamoxifen—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000371	CcSEcCtD
Tamoxifen—Leukopenia—Losartan—type 2 diabetes mellitus	4.82e-05	0.000371	CcSEcCtD
Tamoxifen—Discomfort—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.00037	CcSEcCtD
Tamoxifen—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.79e-05	0.000368	CcSEcCtD
Tamoxifen—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.79e-05	0.000368	CcSEcCtD
Tamoxifen—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.77e-05	0.000367	CcSEcCtD
Tamoxifen—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000367	CcSEcCtD
Tamoxifen—Nausea—Glimepiride—type 2 diabetes mellitus	4.75e-05	0.000365	CcSEcCtD
Tamoxifen—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000365	CcSEcCtD
Tamoxifen—Nausea—Sitagliptin—type 2 diabetes mellitus	4.73e-05	0.000364	CcSEcCtD
Tamoxifen—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.73e-05	0.000364	CcSEcCtD
Tamoxifen—Asthenia—Glyburide—type 2 diabetes mellitus	4.73e-05	0.000364	CcSEcCtD
Tamoxifen—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.73e-05	0.000363	CcSEcCtD
Tamoxifen—Anorexia—Metformin—type 2 diabetes mellitus	4.72e-05	0.000363	CcSEcCtD
Tamoxifen—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	4.71e-05	0.02	CrCbGaD
Tamoxifen—Cough—Losartan—type 2 diabetes mellitus	4.7e-05	0.000361	CcSEcCtD
Tamoxifen—Urticaria—Gliclazide—type 2 diabetes mellitus	4.7e-05	0.000361	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000361	CcSEcCtD
Tamoxifen—Alopecia—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000361	CcSEcCtD
Tamoxifen—Fatigue—Valsartan—type 2 diabetes mellitus	4.69e-05	0.00036	CcSEcCtD
Tamoxifen—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.68e-05	0.00036	CcSEcCtD
Tamoxifen—Oedema—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000359	CcSEcCtD
Tamoxifen—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000359	CcSEcCtD
Tamoxifen—Pruritus—Glyburide—type 2 diabetes mellitus	4.66e-05	0.000359	CcSEcCtD
Tamoxifen—Constipation—Valsartan—type 2 diabetes mellitus	4.65e-05	0.000357	CcSEcCtD
Tamoxifen—Infection—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000357	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.64e-05	0.000357	CcSEcCtD
Tamoxifen—Fatigue—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000356	CcSEcCtD
Tamoxifen—Erythema—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000355	CcSEcCtD
Tamoxifen—Pain—Orlistat—type 2 diabetes mellitus	4.59e-05	0.000353	CcSEcCtD
Tamoxifen—Chest pain—Losartan—type 2 diabetes mellitus	4.59e-05	0.000353	CcSEcCtD
Tamoxifen—Myalgia—Losartan—type 2 diabetes mellitus	4.59e-05	0.000353	CcSEcCtD
Tamoxifen—Arthralgia—Losartan—type 2 diabetes mellitus	4.59e-05	0.000353	CcSEcCtD
Tamoxifen—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.58e-05	0.000352	CcSEcCtD
Tamoxifen—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000352	CcSEcCtD
Tamoxifen—Anxiety—Losartan—type 2 diabetes mellitus	4.57e-05	0.000351	CcSEcCtD
Tamoxifen—Rash—Bromocriptine—type 2 diabetes mellitus	4.54e-05	0.000349	CcSEcCtD
Tamoxifen—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.54e-05	0.000349	CcSEcCtD
Tamoxifen—Discomfort—Losartan—type 2 diabetes mellitus	4.53e-05	0.000348	CcSEcCtD
Tamoxifen—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000348	CcSEcCtD
Tamoxifen—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000347	CcSEcCtD
Tamoxifen—Headache—Bromocriptine—type 2 diabetes mellitus	4.52e-05	0.000347	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.51e-05	0.000347	CcSEcCtD
Tamoxifen—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.51e-05	0.000347	CcSEcCtD
Tamoxifen—Dry mouth—Losartan—type 2 diabetes mellitus	4.49e-05	0.000345	CcSEcCtD
Tamoxifen—Anorexia—Irbesartan—type 2 diabetes mellitus	4.45e-05	0.000342	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.45e-05	0.000342	CcSEcCtD
Tamoxifen—Paraesthesia—Metformin—type 2 diabetes mellitus	4.45e-05	0.000342	CcSEcCtD
Tamoxifen—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000342	CcSEcCtD
Tamoxifen—Dyspnoea—Metformin—type 2 diabetes mellitus	4.41e-05	0.000339	CcSEcCtD
Tamoxifen—Oedema—Losartan—type 2 diabetes mellitus	4.4e-05	0.000338	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.39e-05	0.000338	CcSEcCtD
Tamoxifen—Infection—Losartan—type 2 diabetes mellitus	4.37e-05	0.000336	CcSEcCtD
Tamoxifen—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.36e-05	0.000335	CcSEcCtD
Tamoxifen—Dyspepsia—Metformin—type 2 diabetes mellitus	4.36e-05	0.000335	CcSEcCtD
Tamoxifen—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	4.32e-05	0.0184	CrCbGaD
Tamoxifen—Urticaria—Valsartan—type 2 diabetes mellitus	4.32e-05	0.000332	CcSEcCtD
Tamoxifen—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.3e-05	0.000331	CcSEcCtD
Tamoxifen—Decreased appetite—Metformin—type 2 diabetes mellitus	4.3e-05	0.000331	CcSEcCtD
Tamoxifen—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.3e-05	0.00033	CcSEcCtD
Tamoxifen—Orphenadrine—CYP2E1—type 2 diabetes mellitus	4.3e-05	0.0183	CrCbGaD
Tamoxifen—Nausea—Bromocriptine—type 2 diabetes mellitus	4.28e-05	0.000329	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.27e-05	0.000329	CcSEcCtD
Tamoxifen—Fatigue—Metformin—type 2 diabetes mellitus	4.27e-05	0.000328	CcSEcCtD
Tamoxifen—Urticaria—Orlistat—type 2 diabetes mellitus	4.27e-05	0.000328	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000327	CcSEcCtD
Tamoxifen—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.25e-05	0.000327	CcSEcCtD
Tamoxifen—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.25e-05	0.000327	CcSEcCtD
Tamoxifen—Asthenia—Gliclazide—type 2 diabetes mellitus	4.25e-05	0.000326	CcSEcCtD
Tamoxifen—Constipation—Metformin—type 2 diabetes mellitus	4.23e-05	0.000326	CcSEcCtD
Tamoxifen—Angioedema—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000325	CcSEcCtD
Tamoxifen—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000323	CcSEcCtD
Tamoxifen—Anorexia—Losartan—type 2 diabetes mellitus	4.19e-05	0.000322	CcSEcCtD
Tamoxifen—Vomiting—Glyburide—type 2 diabetes mellitus	4.19e-05	0.000322	CcSEcCtD
Tamoxifen—Pruritus—Gliclazide—type 2 diabetes mellitus	4.19e-05	0.000322	CcSEcCtD
Tamoxifen—Methadone—CYP1A2—type 2 diabetes mellitus	4.17e-05	0.0177	CrCbGaD
Tamoxifen—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.00032	CcSEcCtD
Tamoxifen—Rash—Glyburide—type 2 diabetes mellitus	4.15e-05	0.000319	CcSEcCtD
Tamoxifen—Dermatitis—Glyburide—type 2 diabetes mellitus	4.15e-05	0.000319	CcSEcCtD
Tamoxifen—Leukopenia—Ramipril—type 2 diabetes mellitus	4.13e-05	0.000318	CcSEcCtD
Tamoxifen—Headache—Glyburide—type 2 diabetes mellitus	4.13e-05	0.000317	CcSEcCtD
Tamoxifen—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000316	CcSEcCtD
Tamoxifen—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	4.07e-05	0.0173	CrCbGaD
Tamoxifen—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000312	CcSEcCtD
Tamoxifen—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.05e-05	0.000311	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.05e-05	0.000311	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.00031	CcSEcCtD
Tamoxifen—Cough—Ramipril—type 2 diabetes mellitus	4.03e-05	0.00031	CcSEcCtD
Tamoxifen—Fatigue—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.00031	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.01e-05	0.000308	CcSEcCtD
Tamoxifen—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.01e-05	0.000308	CcSEcCtD
Tamoxifen—Constipation—Irbesartan—type 2 diabetes mellitus	4e-05	0.000307	CcSEcCtD
Tamoxifen—Pain—Irbesartan—type 2 diabetes mellitus	4e-05	0.000307	CcSEcCtD
Tamoxifen—Insomnia—Losartan—type 2 diabetes mellitus	3.98e-05	0.000306	CcSEcCtD
Tamoxifen—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.96e-05	0.000304	CcSEcCtD
Tamoxifen—Paraesthesia—Losartan—type 2 diabetes mellitus	3.95e-05	0.000304	CcSEcCtD
Tamoxifen—Urticaria—Metformin—type 2 diabetes mellitus	3.93e-05	0.000302	CcSEcCtD
Tamoxifen—Chest pain—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000302	CcSEcCtD
Tamoxifen—Arthralgia—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000302	CcSEcCtD
Tamoxifen—Myalgia—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000302	CcSEcCtD
Tamoxifen—Dyspnoea—Losartan—type 2 diabetes mellitus	3.92e-05	0.000301	CcSEcCtD
Tamoxifen—Anxiety—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000301	CcSEcCtD
Tamoxifen—Nausea—Glyburide—type 2 diabetes mellitus	3.91e-05	0.000301	CcSEcCtD
Tamoxifen—Abdominal pain—Metformin—type 2 diabetes mellitus	3.91e-05	0.000301	CcSEcCtD
Tamoxifen—Dizziness—Gliclazide—type 2 diabetes mellitus	3.91e-05	0.000301	CcSEcCtD
Tamoxifen—Asthenia—Valsartan—type 2 diabetes mellitus	3.9e-05	0.0003	CcSEcCtD
Tamoxifen—Discomfort—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000299	CcSEcCtD
Tamoxifen—Loperamide—CYP3A4—type 2 diabetes mellitus	3.88e-05	0.0165	CrCbGaD
Tamoxifen—Dyspepsia—Losartan—type 2 diabetes mellitus	3.87e-05	0.000298	CcSEcCtD
Tamoxifen—Asthenia—Orlistat—type 2 diabetes mellitus	3.85e-05	0.000296	CcSEcCtD
Tamoxifen—Pruritus—Valsartan—type 2 diabetes mellitus	3.85e-05	0.000296	CcSEcCtD
Tamoxifen—Dry mouth—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000296	CcSEcCtD
Tamoxifen—Decreased appetite—Losartan—type 2 diabetes mellitus	3.82e-05	0.000294	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.82e-05	0.000294	CcSEcCtD
Tamoxifen—Pruritus—Orlistat—type 2 diabetes mellitus	3.8e-05	0.000292	CcSEcCtD
Tamoxifen—Fatigue—Losartan—type 2 diabetes mellitus	3.79e-05	0.000291	CcSEcCtD
Tamoxifen—Oedema—Ramipril—type 2 diabetes mellitus	3.77e-05	0.00029	CcSEcCtD
Tamoxifen—Vomiting—Gliclazide—type 2 diabetes mellitus	3.76e-05	0.000289	CcSEcCtD
Tamoxifen—Constipation—Losartan—type 2 diabetes mellitus	3.76e-05	0.000289	CcSEcCtD
Tamoxifen—Pain—Losartan—type 2 diabetes mellitus	3.76e-05	0.000289	CcSEcCtD
Tamoxifen—Rash—Gliclazide—type 2 diabetes mellitus	3.73e-05	0.000287	CcSEcCtD
Tamoxifen—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.73e-05	0.000287	CcSEcCtD
Tamoxifen—Promazine—CYP1A2—type 2 diabetes mellitus	3.73e-05	0.0159	CrCbGaD
Tamoxifen—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.72e-05	0.000286	CcSEcCtD
Tamoxifen—Urticaria—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000285	CcSEcCtD
Tamoxifen—Headache—Gliclazide—type 2 diabetes mellitus	3.71e-05	0.000285	CcSEcCtD
Tamoxifen—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.69e-05	0.000284	CcSEcCtD
Tamoxifen—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000284	CcSEcCtD
Tamoxifen—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.68e-05	0.000283	CcSEcCtD
Tamoxifen—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.64e-05	0.00028	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.6e-05	0.000276	CcSEcCtD
Tamoxifen—Dizziness—Valsartan—type 2 diabetes mellitus	3.59e-05	0.000276	CcSEcCtD
Tamoxifen—Anorexia—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000276	CcSEcCtD
Tamoxifen—Benzphetamine—CYP3A4—type 2 diabetes mellitus	3.57e-05	0.0152	CrCbGaD
Tamoxifen—Dizziness—Orlistat—type 2 diabetes mellitus	3.55e-05	0.000273	CcSEcCtD
Tamoxifen—Asthenia—Metformin—type 2 diabetes mellitus	3.55e-05	0.000273	CcSEcCtD
Tamoxifen—Nausea—Gliclazide—type 2 diabetes mellitus	3.51e-05	0.00027	CcSEcCtD
Tamoxifen—Pruritus—Metformin—type 2 diabetes mellitus	3.5e-05	0.000269	CcSEcCtD
Tamoxifen—Urticaria—Losartan—type 2 diabetes mellitus	3.49e-05	0.000269	CcSEcCtD
Tamoxifen—Abdominal pain—Losartan—type 2 diabetes mellitus	3.48e-05	0.000267	CcSEcCtD
Tamoxifen—Vomiting—Valsartan—type 2 diabetes mellitus	3.46e-05	0.000266	CcSEcCtD
Tamoxifen—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.000265	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000264	CcSEcCtD
Tamoxifen—Rash—Valsartan—type 2 diabetes mellitus	3.43e-05	0.000264	CcSEcCtD
Tamoxifen—Dermatitis—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000263	CcSEcCtD
Tamoxifen—Vomiting—Orlistat—type 2 diabetes mellitus	3.42e-05	0.000263	CcSEcCtD
Tamoxifen—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	3.41e-05	0.0145	CrCbGaD
Tamoxifen—Insomnia—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000262	CcSEcCtD
Tamoxifen—Headache—Valsartan—type 2 diabetes mellitus	3.41e-05	0.000262	CcSEcCtD
Tamoxifen—Diarrhoea—Metformin—type 2 diabetes mellitus	3.39e-05	0.00026	CcSEcCtD
Tamoxifen—Rash—Orlistat—type 2 diabetes mellitus	3.39e-05	0.00026	CcSEcCtD
Tamoxifen—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.39e-05	0.00026	CcSEcCtD
Tamoxifen—Dermatitis—Orlistat—type 2 diabetes mellitus	3.38e-05	0.00026	CcSEcCtD
Tamoxifen—Headache—Orlistat—type 2 diabetes mellitus	3.37e-05	0.000259	CcSEcCtD
Tamoxifen—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000258	CcSEcCtD
Tamoxifen—Asthenia—Irbesartan—type 2 diabetes mellitus	3.35e-05	0.000258	CcSEcCtD
Tamoxifen—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000255	CcSEcCtD
Tamoxifen—Pruritus—Irbesartan—type 2 diabetes mellitus	3.31e-05	0.000254	CcSEcCtD
Tamoxifen—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000252	CcSEcCtD
Tamoxifen—Dizziness—Metformin—type 2 diabetes mellitus	3.27e-05	0.000252	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.25e-05	0.00025	CcSEcCtD
Tamoxifen—Fatigue—Ramipril—type 2 diabetes mellitus	3.25e-05	0.00025	CcSEcCtD
Tamoxifen—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.24e-05	0.000249	CcSEcCtD
Tamoxifen—Nausea—Valsartan—type 2 diabetes mellitus	3.23e-05	0.000248	CcSEcCtD
Tamoxifen—Constipation—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000248	CcSEcCtD
Tamoxifen—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000246	CcSEcCtD
Tamoxifen—Nausea—Orlistat—type 2 diabetes mellitus	3.19e-05	0.000245	CcSEcCtD
Tamoxifen—Asthenia—Losartan—type 2 diabetes mellitus	3.15e-05	0.000243	CcSEcCtD
Tamoxifen—Vomiting—Metformin—type 2 diabetes mellitus	3.15e-05	0.000242	CcSEcCtD
Tamoxifen—Rash—Metformin—type 2 diabetes mellitus	3.12e-05	0.00024	CcSEcCtD
Tamoxifen—Dermatitis—Metformin—type 2 diabetes mellitus	3.12e-05	0.00024	CcSEcCtD
Tamoxifen—Pruritus—Losartan—type 2 diabetes mellitus	3.11e-05	0.000239	CcSEcCtD
Tamoxifen—Headache—Metformin—type 2 diabetes mellitus	3.1e-05	0.000238	CcSEcCtD
Tamoxifen—Dizziness—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.000238	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000237	CcSEcCtD
Tamoxifen—Diarrhoea—Losartan—type 2 diabetes mellitus	3.01e-05	0.000231	CcSEcCtD
Tamoxifen—Urticaria—Ramipril—type 2 diabetes mellitus	2.99e-05	0.00023	CcSEcCtD
Tamoxifen—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.98e-05	0.000229	CcSEcCtD
Tamoxifen—Vomiting—Irbesartan—type 2 diabetes mellitus	2.97e-05	0.000228	CcSEcCtD
Tamoxifen—Rash—Irbesartan—type 2 diabetes mellitus	2.95e-05	0.000227	CcSEcCtD
Tamoxifen—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000226	CcSEcCtD
Tamoxifen—Nausea—Metformin—type 2 diabetes mellitus	2.94e-05	0.000226	CcSEcCtD
Tamoxifen—Headache—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000225	CcSEcCtD
Tamoxifen—Dizziness—Losartan—type 2 diabetes mellitus	2.91e-05	0.000224	CcSEcCtD
Tamoxifen—Vomiting—Losartan—type 2 diabetes mellitus	2.8e-05	0.000215	CcSEcCtD
Tamoxifen—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000214	CcSEcCtD
Tamoxifen—Nausea—Irbesartan—type 2 diabetes mellitus	2.77e-05	0.000213	CcSEcCtD
Tamoxifen—Rash—Losartan—type 2 diabetes mellitus	2.77e-05	0.000213	CcSEcCtD
Tamoxifen—Dermatitis—Losartan—type 2 diabetes mellitus	2.77e-05	0.000213	CcSEcCtD
Tamoxifen—Methadone—CYP3A4—type 2 diabetes mellitus	2.76e-05	0.0117	CrCbGaD
Tamoxifen—Headache—Losartan—type 2 diabetes mellitus	2.75e-05	0.000212	CcSEcCtD
Tamoxifen—Orphenadrine—CYP3A4—type 2 diabetes mellitus	2.7e-05	0.0115	CrCbGaD
Tamoxifen—Asthenia—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000208	CcSEcCtD
Tamoxifen—Pruritus—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000205	CcSEcCtD
Tamoxifen—Nausea—Losartan—type 2 diabetes mellitus	2.61e-05	0.000201	CcSEcCtD
Tamoxifen—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000198	CcSEcCtD
Tamoxifen—Dizziness—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000192	CcSEcCtD
Tamoxifen—Promazine—CYP3A4—type 2 diabetes mellitus	2.47e-05	0.0105	CrCbGaD
Tamoxifen—Vomiting—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000184	CcSEcCtD
Tamoxifen—Rash—Ramipril—type 2 diabetes mellitus	2.38e-05	0.000183	CcSEcCtD
Tamoxifen—Dermatitis—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000183	CcSEcCtD
Tamoxifen—Headache—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000182	CcSEcCtD
Tamoxifen—Nausea—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000172	CcSEcCtD
Tamoxifen—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.27e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	1.27e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.26e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.26e-06	1.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.26e-06	1.45e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	1.25e-06	1.45e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	1.25e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.25e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.25e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.25e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—type 2 diabetes mellitus	1.25e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.25e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.24e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.24e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.24e-06	1.43e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.23e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.22e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.22e-06	1.41e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.22e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.21e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.21e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.2e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.2e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.19e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.19e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.19e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.18e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.17e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.17e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.17e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.17e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.17e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.16e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.16e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.16e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.16e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.16e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.16e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.15e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.15e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.15e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.15e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.15e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.14e-06	1.32e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.14e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.14e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.14e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.13e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.13e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	1.13e-06	1.3e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.12e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.12e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.12e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.11e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.11e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.11e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.11e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.11e-06	1.28e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-06	1.27e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.09e-06	1.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.08e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.07e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.07e-06	1.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.06e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.06e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.05e-06	1.21e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.04e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.04e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.03e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.02e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.02e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.02e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.01e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.01e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.01e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1e-06	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	9.98e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.98e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	9.97e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	9.97e-07	1.15e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	9.93e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	9.92e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	9.9e-07	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	9.81e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	9.8e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	9.8e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	9.77e-07	1.13e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	9.73e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.69e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	9.69e-07	1.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	9.66e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	9.65e-07	1.11e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.59e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	9.57e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	9.57e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	9.54e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	9.53e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	9.51e-07	1.1e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	9.49e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.49e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	9.47e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	9.47e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	9.47e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	9.43e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	9.42e-07	1.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	9.39e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	9.35e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	9.35e-07	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	9.32e-07	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	9.32e-07	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	9.25e-07	1.07e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	9.19e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	9.17e-07	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	9.09e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	9.08e-07	1.05e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.06e-07	1.04e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	9.02e-07	1.04e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	8.99e-07	1.04e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.96e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.94e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	8.94e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	8.94e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	8.93e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	8.93e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	8.91e-07	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	8.89e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	8.88e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	8.86e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	8.86e-07	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	8.81e-07	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	8.68e-07	1e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	8.66e-07	9.98e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.63e-07	9.94e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	8.57e-07	9.88e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.52e-07	9.82e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	8.51e-07	9.8e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.35e-07	9.62e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	8.35e-07	9.62e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	8.31e-07	9.57e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	8.2e-07	9.45e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	8.2e-07	9.45e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	8.18e-07	9.43e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	8.18e-07	9.42e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—INS—type 2 diabetes mellitus	8.15e-07	9.39e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.13e-07	9.37e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	8.02e-07	9.24e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	7.98e-07	9.2e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	7.83e-07	9.02e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	7.77e-07	8.95e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	7.76e-07	8.94e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.7e-07	8.87e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	7.7e-07	8.87e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	7.68e-07	8.84e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	7.66e-07	8.83e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	7.65e-07	8.82e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.64e-07	8.8e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.61e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.61e-07	8.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	7.56e-07	8.71e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.53e-07	8.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	7.5e-07	8.64e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	7.47e-07	8.6e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.47e-07	8.6e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.34e-07	8.46e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.32e-07	8.43e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.32e-07	8.43e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.32e-07	8.43e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.14e-07	8.23e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.14e-07	8.23e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.14e-07	8.23e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	7.04e-07	8.11e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.01e-07	8.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	6.98e-07	8.04e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	6.93e-07	7.99e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	6.86e-07	7.91e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	6.84e-07	7.88e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	6.73e-07	7.76e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	6.73e-07	7.76e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	6.69e-07	7.71e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	6.68e-07	7.69e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.67e-07	7.69e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.67e-07	7.69e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	6.66e-07	7.67e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.63e-07	7.64e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	6.58e-07	7.58e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	6.53e-07	7.53e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.5e-07	7.49e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.31e-07	7.27e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.19e-07	7.13e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.16e-07	7.09e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.1e-07	7.03e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	6.07e-07	7e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	6.02e-07	6.94e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6e-07	6.91e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	5.96e-07	6.87e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.9e-07	6.79e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.88e-07	6.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	5.81e-07	6.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.7e-07	6.57e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.7e-07	6.57e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.63e-07	6.48e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	5.52e-07	6.36e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.22e-07	6.01e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.19e-07	5.98e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.12e-07	5.9e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.02e-07	5.78e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.6e-07	5.3e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	4.45e-07	5.13e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.4e-07	5.07e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.4e-07	5.07e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	4.36e-07	5.02e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	4.35e-07	5.01e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	4.11e-07	4.74e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.03e-07	4.64e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	3.77e-07	4.34e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.36e-07	3.88e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.28e-07	3.78e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.09e-07	3.57e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.07e-07	3.53e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.62e-07	3.02e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.02e-07	2.33e-06	CbGpPWpGaD
